Orly Avni
Bar-Ilan University, Israel
Title: Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome
Biography
Biography: Orly Avni
Abstract
Dilated cardiomyopathy (DCM) is a life threatening disorder whose genetic basis is heterogeneous and mostly unknown. Five Arab-Christian-infants, ages 4-30 months from four families were diagnosed with DCM associated with mild skin, teeth and hair abnormalities. All passed away before age 3. A homozygous sequence variation creating a premature stop codon at PPP1R13L encoding the iASPP protein, was identified in three infants, and in the mother of the other two. Patients’ fibroblasts and PPP1R13L-knocked down human fibroblasts presented higher expression levels of pro-inflammatory cytokine genes in response to Lipopolysaccharide, as well as ppp1r13l-knocked down murine cardiomyocytes and hearts of ppp1r13l-deficient mice. The hypersensitivity to Lipopolysaccharide was NF-kB-dependent, and its inducible binding activity to promoters of pro-inflammatory cytokine genes was elevated in patients’ fibroblasts. RNA-sequencing of ppp1r13l-knocked down murine cardiomyocytes and of hearts derived from different stages of DCM development in ppp1r13l-deficient mice revealed the crucial role of iASPP in dampening cardiac inflammatory response. Our results determined PPP1R13L as the gene underlying a novel autosomal recessive cardio cutaneous syndrome in humans, and strongly suggest that the fatal DCM during infancy is a consequence of failure to regulate transcriptional pathways necessary for tuning cardiac threshold response to common inflammatory stressors.
References:
1. T. C. Falik-Zaccai, Y. Barsheshet, H. Mandel, M. Segev, A. Lorber, S. Gelberg, L. Kalfon, S. Ben Haroush, A. Shalata, L. Gelernter-Yaniv, S. Chaim, D. Raviv Shay, M. Khayat, M. Werbner, I. Levi, Y. Shoval, G. Tal, S. Shalev, E. Reuveni, E. Avitan-Hersh, E. Vlodavsky, L. Appl-Sarid, D. Goldsher, R. Bergman, Z. Segal, O. Bitterman-Deutsch, O. Avni, Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome. EMBO molecular medicine, (2017); (10.15252/emmm.201606523).
2. R. Hod-Dvorai, E. Jacob, Y. Boyko, O. Avni, The binding activity of Mel-18 at the Il17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines. Eur J Immunol 41, 2424-2435 (2011).
3. E. Jacob, R. Hod-Dvorai, O. L. Ben-Mordechai, Y. Boyko, O. Avni, Dual function of polycomb group proteins in differentiated murine T helper (CD4+) cells. Journal of molecular signaling 6, 5 (2011).
4. E. Jacob, R. Hod-Dvorai, S. Schif-Zuck, O. Avni, Unconventional association of the polycomb group proteins with cytokine genes in differentiated T helper cells. J Biol Chem 283, 13471-13481 (2008).
5. O. Shamriz, H. Mizrahi, M. Werbner, Y. Shoenfeld, O. Avni, O. Koren, Microbiota at the crossroads of autoimmunity. Autoimmun Rev 15, 859-869 (2016); (10.1016/j.autrev.2016.07.012).